Monoswift® is a synthetic absorbable monofilament surgical suture, composed of Poly(Glycolide-Co-Caprolactone) (PGCL). PGCL
synthetic absorbable monofilament sutures are available dyed with FD&C violet 2 or undyed (natural). PGCL synthetic absorbable
monofilament suture meets all requirements established by the United States Pharmacopoeia, except for diameter. Excellent holding
strength. Smooth tissue passage, excellent handling, exceptional suppleness, and good knot security. Non-wicking material helps
prevent bacterial migration along the suture line. Monoswift® synthetic absorbable monofilament sutures are indicated for use in
soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological surgery, micro-surgery, or ophthalmic
surgery. These sutures, being absorbable, are not to be used where extended approximation of tissue is required. The use of this
suture may be inappropriate in elderly, malnourished, and debilitated patients, or any patients suffering from conditions that may
delay wound healing. Implantation studies in animals indicate that PGCL suture retains approximately 70% of its original tensile
strength at 7 days post implantation, approximately 40% of its original tensile strength at 14 days, and approximately 12% at 21
days post implantation. Absorption begins as a loss of tensile strength without appreciable loss of mass, absorption of Monoswift®
is essentially complete between 91 and 120 days. For soft tissue approximation and/or ligation.
synthetic absorbable monofilament sutures are available dyed with FD&C violet 2 or undyed (natural). PGCL synthetic absorbable
monofilament suture meets all requirements established by the United States Pharmacopoeia, except for diameter. Excellent holding
strength. Smooth tissue passage, excellent handling, exceptional suppleness, and good knot security. Non-wicking material helps
prevent bacterial migration along the suture line. Monoswift® synthetic absorbable monofilament sutures are indicated for use in
soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological surgery, micro-surgery, or ophthalmic
surgery. These sutures, being absorbable, are not to be used where extended approximation of tissue is required. The use of this
suture may be inappropriate in elderly, malnourished, and debilitated patients, or any patients suffering from conditions that may
delay wound healing. Implantation studies in animals indicate that PGCL suture retains approximately 70% of its original tensile
strength at 7 days post implantation, approximately 40% of its original tensile strength at 14 days, and approximately 12% at 21
days post implantation. Absorption begins as a loss of tensile strength without appreciable loss of mass, absorption of Monoswift®
is essentially complete between 91 and 120 days. For soft tissue approximation and/or ligation.